Related Experiment Video
Updated: Dec 31, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic
Cibelle Mariano1,2, Ana Catarina Alves1,2, Ana Margarida Medeiros1,2
1Cardiovascular Research Group, Research and Development Unit, Department of Health Promotion and Chronic Diseases, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Insights
Genetic testing identified a cause for familial hypercholesterolaemia (FH) in 69% of Portuguese patients. This included FH-causing mutations in 39% and polygenic hypercholesterolaemia in 29%, highlighting the need for comprehensive genetic evaluation.
Area of Science:
- Genetics
- Cardiology
- Biochemistry
Background:
- Familial hypercholesterolaemia (FH) is a monogenic disorder leading to high LDL-C and increased cardiovascular risk.
- Genetic variants are identified in only 40-50% of clinically diagnosed FH cases globally.
- Comprehensive genetic characterization is crucial for understanding FH etiology.
Purpose of the Study:
- To determine the genetic causes of the FH phenotype in Portuguese patients.
- To investigate both monogenic and polygenic hypercholesterolaemia in a clinical FH cohort.
- To assess the diagnostic yield of genetic testing in FH.
Main Methods:
- Analysis of 731 index patients meeting Simon Broome criteria between 1999-2017.
- Sanger sequencing of key genes (LDLR, APOB, PCSK9, APOE, LIPA, LDLRAP1, ABCG5/8).
- Validation of a 6-SNP genetic risk score (GRS) for polygenic hypercholesterolaemia.
Main Results:
- FH-causing mutations identified in 39% of patients (94% in LDLR, 5% APOB, 1% PCSK9).
- Polygenic hypercholesterolaemia identified in at least 29% of patients.
- A genetic cause for the FH phenotype was established in 69% of the cohort.
Conclusions:
- A significant proportion of FH phenotypes in Portugal are attributable to monogenic mutations or polygenic hypercholesterolaemia.
- Comprehensive genetic investigation, including polygenic risk scores, is essential for accurate FH diagnosis.
- Identifying the genetic basis of FH is critical for appropriate patient management and cardiovascular risk reduction.
Abstract:
Familial hypercholesterolaemia (FH) is a monogenic disorder characterised by high low-density lipoprotein cholesterol (LDL-C) concentrations and increased cardiovascular risk. However, in clinically defined FH cohorts worldwide, an FH-causing variant is only found in 40%-50% of the cases. The aim of this work was to characterise the genetic cause of the FH phenotype in Portuguese clinical FH patients. Between 1999 and 2017, 731 index patients (311 children and 420 adults) who met the Simon Broome diagnostic criteria had been referred to our laboratory. LDLR, APOB, PCSK9, APOE, LIPA, LDLRAP1, ABCG5/8 genes were analysed by polymerase chain reaction amplification and Sanger sequencing. The 6-SNP LDL-C genetic risk score (GRS) for polygenic hypercholesterolaemia was validated in the Portuguese population and cases with a GRS over the 25th percentile were considered to have a high likelihood of polygenic hypercholesterolaemia. An FH-causing mutation was found in 39% of patients (94% in LDLR, 5% APOB and 1% PCSK9), while at least 29% have polygenic hypercholesterolaemia and 1% have other lipid disorders. A genetic cause for the FH phenotype was found in 503 patients (69%). All known causes of the FH phenotype should be investigated in FH cohorts to ensure accurate diagnosis and appropriate management.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pleiotropy
Polygenic Traits
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

